Novo Nordisk India sets patient-centred price of Rs. 202/day for starting dose of Ozempic and Wegovy
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
The initiative will focus on creating healthier early-life environments, promoting physical activity, identifying risks early, and strengthening preparedness within primary health care systems
Oral semaglutide is a co-formulation of GLP-1RA semaglutide with an absorption enhancer SNAC which protects semaglutide from undergoing degradation in the stomach
Subscribe To Our Newsletter & Stay Updated